Avance Clinical is Attending Biotech Showcase 2025
Avance Clinical, with over 30 years of experience as a leading full-service Contract Research Organization (CRO), is looking forward to once again meet with biotechs at Biotech Showcase 2025.
With over 30 years of experience as a full-service Contract Research Organization (CRO) and known for our leading EARLY PHASE specialist clinical research in Australia, we are committed to delivering high-quality, compliant clinical trials.
We have experience across 250+ therapeutic areas in Phase I in Australia. In Phase II/III we specialize in oncology, CNS disorders, rare diseases, and cell and gene therapies. Our global footprint and deep scientific expertise allow us to offer seamless clinical trial solutions, supporting biotech companies from early to late-phase studies.
Why Partner with Avance Clinical?
The Australian Advantage for Accelerated Start-Up
Take advantage of Australia’s regulatory environment, where biotech companies can initiate clinical trials without an IND, significantly reducing regulatory timelines by up to 12 months. On top of that, companies conducting early-phase clinical trials in Australia benefit from a 43.5% government rebate on clinical trial costs, making Australia an ideal location for early-stage studies.
Extensive Network and Proven Expertise
With access to over 2,000 clinical sites across the United States, and a strong operational presence in Asia and Europe, Avance Clinical excels in patient recruitment and trial management. Our dedicated in-house teams of experts ensure regulatory compliance and efficient project delivery, helping you achieve key milestones on time.
Asia Advantage
Avance Clinical’s hub in Seoul, South Korea, supports North American and European biotechs looking to expand into Asia for later-phase, multi-regional studies. The region offers cost-effective trial solutions, access to a diverse population of over 4.5 billion people, and cutting-edge technological infrastructure. Our expertise in both Asia and Australia allows us to offer biotechs a unique advantage in their global drug development strategies.
North America Advantage
North America is a cornerstone of Avance Clinical’s operations, supporting more than 80% of our biotech clients. Our ClinicReady program facilitates early-phase trials, while our GlobalReady program ensures smooth transitions to later phases in North America and beyond. The FDA’s regulatory approvals are recognized globally, making North America a crucial hub for successful biotech development.
Connect with Us at
Biotech Showcase 2025
Meet with our expert team at Biotech Showcase 2025 to explore how Avance Clinical can accelerate your clinical trials, optimize your drug development strategy, and deliver faster, more efficient outcomes. We look forward to discussing how we can become your trusted CRO partner, supporting you every step of the way.
Read more about why Avance Clinical is the partner of choice for US Biotechs here.
